Paper41373448
Unraveling the Role of BAG3 in Hepatic Fibrosis: Genetic and Biomarker Insights in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Motta BM and 6 others. Int J Mol Sci, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Unraveling the Role of BAG3 in Hepatic Fibrosis: Genetic and Biomarker Insights in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Papers, record 41373448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41373448
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Unraveling the Role of BAG3 in Hepatic Fibrosis: Genetic and Biomarker Insights in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Cirrhosis | Major topic |
| Adaptor Proteins, Signal Transducing | Major topic |
| Apoptosis Regulatory Proteins | Major topic |
| Fatty Liver | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Biomarkers | |
| Membrane Proteins | |
| Lipase | |
| Genetic Predisposition to Disease | |
| Aged | |
| Adult | |
| Polymorphism, Single Nucleotide | |
| Genotype | |
| Alleles | |
| Acyltransferases | |
| Phospholipases A2, Calcium-Independent |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18082745 | Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. | Gastroenterology | 2008 | https://conductscience.org/library/papers/18082745 | PubMed |
| 2 | 28130788 | Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. | Hepatology | 2017 | https://conductscience.org/library/papers/28130788 | PubMed |
| 3 | 32044314 | MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. | Gastroenterology | 2020 | https://conductscience.org/library/papers/32044314 | PubMed |
| 4 | 35063601 | Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events. | J Hepatol | 2022 | https://conductscience.org/library/papers/35063601 | PubMed |
| 5 | 32044315 | Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis. | Gastroenterology | 2020 | https://conductscience.org/library/papers/32044315 | PubMed |
| 6 | 24927523 | TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24927523 | PubMed |
| 7 | 34741483 | BAG3 induces α-SMA expression in human fibroblasts and its over-expression correlates with poorer survival in fibrotic cancer patients. | J Cell Biochem | 2022 | https://conductscience.org/library/papers/34741483 | PubMed |
| 8 | 38976307 | Overexpression of BAG3 (Bcl2-associated athanogene 3) in serum and skin of patients with systemic sclerosis. | Clin Exp Rheumatol | 2024 | https://conductscience.org/library/papers/38976307 | PubMed |
| 9 | 35241649 | Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth. | Cell Death Discov | 2022 | https://conductscience.org/library/papers/35241649 | PubMed |
| 10 | 37689385 | The Role of Endoplasmic Reticulum in Lipotoxicity during Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Pathogenesis. | Am J Pathol | 2023 | https://conductscience.org/library/papers/37689385 | PubMed |
| 11 | 21472004 | BAG3: a multifaceted protein that regulates major cell pathways. | Cell Death Dis | 2011 | https://conductscience.org/library/papers/21472004 | PubMed |
| 12 | 38851997 | EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). | J Hepatol | 2024 | https://conductscience.org/library/papers/38851997 | PubMed |
| 13 | 24978903 | TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. | Nat Commun | 2014 | https://conductscience.org/library/papers/24978903 | PubMed |
| 14 | 28737513 | Loss-of-function mutations in co-chaperone BAG3 destabilize small HSPs and cause cardiomyopathy. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28737513 | PubMed |
| 15 | 31024089 | Past, present and future perspectives in nonalcoholic fatty liver disease. | Nat Rev Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/31024089 | PubMed |
| 16 | 21381068 | Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. | Hepatology | 2011 | https://conductscience.org/library/papers/21381068 | PubMed |
| 17 | 36740046 | Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties. | J Hepatol | 2023 | https://conductscience.org/library/papers/36740046 | PubMed |
| 18 | 26707365 | Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. | Hepatology | 2016 | https://conductscience.org/library/papers/26707365 | PubMed |
| 19 | 34166721 | EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. | J Hepatol | 2021 | https://conductscience.org/library/papers/34166721 | PubMed |
| 20 | 27742777 | PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis. | Hum Mol Genet | 2016 | https://conductscience.org/library/papers/27742777 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAG3 | 9531 | PubTator's text mining | https://conductscience.org/library/genes/9531 | NCBI Gene |
| PNPLA3 | 80339 | PubTator's text mining | https://conductscience.org/library/genes/80339 | NCBI Gene |
| TM6SF2 | 53345 | PubTator's text mining | https://conductscience.org/library/genes/53345 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41373448
GET https://conductscience.org/api/papers/v1/41373448/references?page=2